You are here: Home / Diseases & Conditions / Common Prostate Cancer Treatment May Increase Risk for Alzheimer’...
Oncologists are taking a look at a common prostate cancer treatment, that may double the risk for Alzheimer’s disease. Although more research has to be done, they are closely taking a look into why this could be happening.
“It’s called androgen deprivation therapy, and it’s aimed at lowering levels of testosterone, the “male” hormone that fuels some types of prostate cancer.”
“The study of more than 16,000 men being treated for prostate cancer showed that those who got any kind of androgen deprivation therapy had nearly twice the risk of developing Alzheimer’s over the next 2 ½ years as men getting other treatments.”
“Those treated for more than a year had more than twice the risk of an Alzheimer’s diagnosis.”
Read the full article: Common Prostate Cancer Treatment May Double Risk for Alzheimer’s
Recent Posts
- The American Health Council Appoints Dr. James Bashkin, D.Phil. to the Physician Board March 31, 2020
- The American Health Council Appoints Dr. Robert W. Letton, MD to the Physician Board March 19, 2020
- The American Health Council Appoints Dr. Akwasi Adjei to the Industry Board January 17, 2020
- The American Health Council Appoints Dr. Nelson Leung to the Physician Board January 17, 2020
- The American Health Council Appoints Ms. Karie Soost to the Physician Board January 17, 2020
- The American Health Council Appoints Mr. Gregory King to the Industry Board January 17, 2020
